Events

CEO Wout Brusselaers will present as part of "The Challenge, In Partnership With HIMSS And HealthXL" session at the Cleveland Clinic Medical Innovation Summit.

Cleveland Clinic Innovations hosts the Medical Innovation Summit each fall as a way to bring together all stakeholders in healthcare to build the relationships and ignite the technologies that will advance patient care. With The Challenge, Cleveland Clinic, HIMSS, and HealthXL are converging their networks, market knowledge, and clinical expertise to find the company that is best positioned to push healthcare into new realms of payment reform, care access, patient engagement, or operational efficiency.

Brian Dolan, co-founder and chief scientist of Deep 6 AI, will join the Digital Health Startup session at the SixThirty Conference 2017:
Transforming Healthcare with Data.

Transforming Healthcare with Data explores the challenges and opportunities in digital healthcare. The conference will bring together healthcare professionals, data experts, civic leaders, and entrepreneurs to discuss how we can use data-driven solutions and digital technology can increase the access to healthcare and improve the quality of care.

Brian Dolan, Deep 6 AI's co-founder and chief scientist, will speak about using artificial intelligence and natural language processing in the fight against disease at the Southern California Big Data Discovery Summit at Azusa Pacific University. The SoCal Big Data Discovery Summit provides researchers and analysts, from a variety of disciplines, opportunities to share information and research findings on big data analytics, including database and data warehousing, data mining, text mining, business intelligence, machine learning, pattern recognition, and data visualization.

Wout Brusselaers, CEO of Deep 6 AI, will speak at MAGI’s Clinical Research Conference - 2017 West as part of the (W858a) Master Class: Patient Recruiting & Retention workshop. Wout will discuss challenges associated with recruiting patients for clinical trials using EHR data.

MAGI is streamlining clinical research by standardizing best practices for clinical research operations, business and regulatory compliance. Its 10,000+ members represent clinical research sponsors, sites and CROs. MAGI's Clinical Research Conference - 2017 West offers 100+ sessions and workshops in six tracks - clinical operations and project management, site management, contracts, budgets & billing, regulatory compliance, and special topics - with 22+ contact hours available for CME, CNE, CLE, CCB and other credits.

Wout Brusselaers, CEO of Deep 6 AI, will present at The Future of Clinical Research in Canada. The Canadian Chapter of ACRP in collaboration with the MaRS Discovery District is proud to present a day of discussion on upcoming trends and topics in Canadian clinical research.

Deep 6 AI will participate in CNS Summit 2017's Innovation Showcase. CNS Summit is a platform for change and a community passionate about shaping the future, with a focus on collaboration, innovation, and technology. Its mission is to have a positive impact on the success of clinical development programs. CNS Summit 2017, developed by life sciences leaders themselves, brings together the top leaders in clinical development to shape the future of clinical development.

Wout Brusselaers, Deep 6 AI's CEO and co-founder, will co-present "Finding the ROI of AI" with Bobbie J. Rimel, MD of Cedars-Sinai Medical Center at HIMSS18.

The 2018 HIMSS Conference & Exhibition, March 5-9, 2018, brings together 40,000+ healthcare IT professionals, clinicians, executives and vendors from around the world.

Wout Brusselaers, Deep 6 AI's CEO and co-founder, will present as part of the "Creating Synergies Between Health Care and Clinical Trial Data Through Technology" session at the Bridging Clinical Research & Clinical Health Care Conference.

Poor recruitment is the leading cause of clinical trial failure. Less than 3% of patients and physicians participate. The Bridging Clinical Research & Clinical Health Care Collaborative is committed to getting another 3% of patients and physicians involved — a small increase that would have an enormous impact on clinical trials and the future of health care.